Yuki Kageyama to STAT3 Transcription Factor
This is a "connection" page, showing publications Yuki Kageyama has written about STAT3 Transcription Factor.
Connection Strength
2.244
-
Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer. Anticancer Res. 2026 May; 46(5):2445-2453.
Score: 0.832
-
STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-?-induced Apoptosis in Urothelial Cancer. Anticancer Res. 2024 May; 44(5):1925-1930.
Score: 0.725
-
Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma. Biochem Biophys Res Commun. 2023 10 08; 676:165-170.
Score: 0.687